Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 29, Issue 6, 2010, Pages 665-671

  Kastelijn, Elisabeth A ^a   van Moorsel, Coline H M ^a   Rijkers, Ger T ^a   Ruven, Henk J T ^a   Karthaus, Vincent ^a   Kwakkel van Erp, Johanna M ^b   van de Graaf, E A ^b   Zanen, Pieter ^b   van Kessel, Diana A ^a   Grutters, Jan C ^a,b   van den Bosch, Jules M M ^a,b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

bronchiolitis obliterans syndrome; innate immunity; lung transplantation; single nucleotide polymorphisms; Toll like receptors

Indexed keywords

BASILIXIMAB; DNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENOTYPE; GRAFT RECIPIENT; HUMAN; INNATE IMMUNITY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

ADULT; ALLELES; BRONCHIOLITIS OBLITERANS; FEMALE; GENOTYPE; HUMANS; IMMUNITY, INNATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 77952554283     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.12.013     Document Type: Article

References (34)

1. Trulock E.P., Christie J.D., Edwards L.B., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 26 (2007) 782-795
2. Grossman E.J., and Shilling R.A. Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Transplant Res 153 (2009) 153-165
3. Palmer S.M., Burch L.H., Trindade A.J., et al. Innate immunity influences long-term outcomes after human lung transplant. Am J Respir Crit Care Med 171 (2005) 780-785
4. Alegre M.L., Chen L., Wang T., et al. Antagonistic effect of toll-like receptor signaling and bacterial infections on transplantation tolerance. Transplantation 87 suppl (2009) S77-S79
5. Alegre M.L., Goldstein D.R., and Chong A.S. Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant 13 (2008) 358-365
6. Goldstein D.R. Toll-like receptors and other links between innate and acquired alloimmunity. Curr Opin Immunol 16 (2004) 538-544
7. Kim I.K., Bedi D.S., Denecke C., et al. Impact of innate and adaptive immunity on rejection and tolerance. Transplantation 86 (2008) 889-894
8. Chen L., Wang T., Zhou P., et al. TLR engagement prevents transplantation tolerance. Am J Transplant 6 (2006) 2282-2291
9. Porrett P.M., Yuan X., LaRosa D.F., et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 181 (2008) 1692-1699
10. Goldstein D.R., and Palmer S.M. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation. J Heart Lung Transplant 24 (2005) 1721-1729
11. Palmer S.M., Klimecki W., Yu L., et al. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Transplant 7 (2007) 693-699
12. Girnita D.M., Webber S.A., and Zeevi A. Clinical impact of cytokine and growth factor genetic polymorphisms in thoracic organ transplantation. Clin Lab Med 28 (2008) 423-440
13. Palmer S.M., Burch L.H., Davis R.D., et al. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med 168 (2003) 628-632
14. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
15. de Bakker P.I., Yelensky R., Pe'er I., et al. Efficiency and power in genetic association studies. Nat Genet 37 (2005) 1217-1223
16. Stephens M., and Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 76 (2005) 449-462
17. Barrett J.C., Fry B., Maller J., et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
18. Eid A.J., Brown R.A., Paya C.V., et al. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 84 (2007) 511-516
19. Lien E., Sellati T.J., Yoshimura A., et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274 (1999) 33419-33425
20. Merx S., Neumaier M., Wagner H., et al. Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene. Hum Mol Genet 16 (2007) 1225-1232
21. Schroder N.W., Diterich I., Zinke A., et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol 175 (2005) 2534-2540
22. Ogus A.C., Yoldas B., Ozdemir T., et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 23 (2004) 219-223
23. Ben-Ali M., Barbouche M.R., Bousnina S., et al. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin Diagn Lab Immunol 11 (2004) 625-626
24. Xu Y., Tao X., Shen B., et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408 (2000) 111-115
25. Nicod L.P. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 3 (2006) 444-449
26. Husain A.N., Siddiqui M.T., Holmes E.W., et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 159 (1999) 829-833
27. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 185-192
28. Lazarus R., Klimecki W.T., Raby B.A., et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies. Genomics 81 (2003) 85-91
29. Carvalho A., Pasqualotto A.C., Pitzurra L., et al. Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis 197 (2008) 618-621
30. Bozza S., Gaziano R., Bonifazi P., et al. Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo. Int Immunol 19 (2007) 1261-1270
31. Tabeta K., Georgel P., Janssen E., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101 (2004) 3516-3521
32. Porrett P.M., Yuan X., LaRosa D.F., et al. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J Immunol 181 (2008) 1692-1699
33. Mamessier E., Lorec A.M., Thomas P., et al. T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 84 (2007) 908-916
34. Meloni F., Vitulo P., Bianco A.M., et al. Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77 (2004) 762-766